e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Collagen remodelling by airway smooth muscle is resistant to steroids and beta 2-agonists
Bourke J.E., Li X., Foster S.R., Wee E., Dagher H., Ziogas J., Harris T., Bonacci J.V., Stewart A.G.
Source:
Eur Respir J 2011; 37: 173-182
Journal Issue:
January
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bourke J.E., Li X., Foster S.R., Wee E., Dagher H., Ziogas J., Harris T., Bonacci J.V., Stewart A.G.. Collagen remodelling by airway smooth muscle is resistant to steroids and beta 2-agonists. Eur Respir J 2011; 37: 173-182
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Pathophysiology of bronchial smooth muscle remodelling in asthma
Source: Eur Respir J 2010; 36: 1174-1184
Year: 2010
Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta
2
-adrenoceptor agonists in airway smooth muscle
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Long-term effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in severe asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells
Source: Eur Respir J 2004; 24: Suppl. 48, 251s
Year: 2004
Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Distribution of increased airway smooth muscle thickness and airway inflammation in asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Contractility of bronchial smooth muscle and changes during disease
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Contribution of bronchial smooth muscle to inflammation
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017
Kinetics of in vitro bronchoconstriction in an elastolytic mouse model of emphysema
Source: Eur Respir J 2007; 30: 691-700
Year: 2007
A comparison of beta
2
-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
Source: Eur Respir J 2007; 30: 653-661
Year: 2007
Corticosteroids and beta2-agonists modify hyaluronic acid homeostasis in human airway smooth muscle cells in asthma and COPD
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Treating asthma means treating airway smooth muscle cells
Source: Eur Respir J 2008; 32: 265-274
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept